The intraocular administration of vascular endothelial growth factor inhibitors (anti-VEGF) or the delivery of neuroprotective agents is commonly adopted for the treatment of AMD, DR, and DME, which could be associated to laser treatment for a synergistic effect [207,212]. Here, VEGFA is linked to age-related macular degeneration.